As of 2025-04-21, the Relative Valuation of Arcus Biosciences Inc (RCUS) is (62.84) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.88 USD, the upside of Arcus Biosciences Inc based on Relative Valuation is -897.4%.
The range of the Relative Valuation is (49.47) - (72.19) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.5x - 32.0x | 25.2x |
| Forward P/E multiples | 16.5x - 27.0x | 21.8x |
| Fair Price | (49.47) - (72.19) | (62.84) |
| Upside | -727.7% - -1016.2% | -897.4% |
| Date | P/E |
| 2025-04-04 | -2.57 |
| 2025-04-03 | -2.68 |
| 2025-04-02 | -2.95 |
| 2025-04-01 | -2.88 |
| 2025-03-31 | -2.94 |
| 2025-03-28 | -3.06 |
| 2025-03-27 | -3.18 |
| 2025-03-26 | -3.09 |
| 2025-03-25 | -3.14 |
| 2025-03-24 | -3.41 |
| 2025-03-21 | -3.34 |
| 2025-03-20 | -3.39 |
| 2025-03-19 | -3.40 |
| 2025-03-18 | -3.36 |
| 2025-03-17 | -3.42 |
| 2025-03-14 | -3.49 |
| 2025-03-13 | -3.57 |
| 2025-03-12 | -3.63 |
| 2025-03-11 | -3.70 |
| 2025-03-10 | -3.52 |
| 2025-03-07 | -3.58 |
| 2025-03-06 | -3.75 |
| 2025-03-05 | -3.67 |
| 2025-03-04 | -3.62 |
| 2025-03-03 | -3.93 |
| 2025-02-28 | -4.07 |
| 2025-02-27 | -3.70 |
| 2025-02-26 | -3.79 |
| 2025-02-25 | -3.83 |
| 2025-02-24 | -3.80 |
| 2025-02-21 | -4.14 |
| 2025-02-20 | -4.02 |
| 2025-02-19 | -4.15 |
| 2025-02-18 | -4.10 |
| 2025-02-14 | -4.90 |
| 2025-02-13 | -4.75 |
| 2025-02-12 | -4.49 |
| 2025-02-11 | -4.48 |
| 2025-02-10 | -4.66 |
| 2025-02-07 | -4.69 |
| 2025-02-06 | -4.87 |
| 2025-02-05 | -5.08 |
| 2025-02-04 | -5.02 |
| 2025-02-03 | -4.94 |
| 2025-01-31 | -4.82 |
| 2025-01-30 | -5.00 |
| 2025-01-29 | -4.87 |
| 2025-01-28 | -4.90 |
| 2025-01-27 | -5.04 |
| 2025-01-24 | -4.92 |